skip to main content

Analysis of Planning and Drug Procurement at Kragan II Public Health Center during Covid-19 Pandemic

*Fitrotul Maulidiyyah  -  Department of Public Health, Universitas Negeri Semarang, Sekaran, Kec. Gn. Pati, Kota Semarang|Universitas Negeri Semarang, Indonesia
Bambang Budi Rahardjo  -  Department of Public Health, Universitas Negeri Semarang, Sekaran, Kec. Gn. Pati, Kota Semarang|Universitas Negeri Semarang, Indonesia
Open Access Copyright (c) 2022 Journal of Public Health for Tropical and Coastal Region

Citation Format:
Abstract

Introduction: Based on the results of a preliminary study at the Kragan II Health Center, Kragan District, Rembang Regency, it was found that problems in drug procurement activities were located on the Large Pharmaceutical Trader or Pedagang Besar Farmasi (PBF). In addition, the COVID-19 pandemic has also affected the budget cuts for the procurement of drugs at the Kragan II Health Center.

Methods: This research was descriptive qualitative research. Data collection techniques use in-depth interviews and observation techniques. The sampling technique used was purposive sampling and data were analyzed using the Miles and Huberman model.

Results: The results showed that the process of planning and supplying drugs at the Kragan II Health Center had not gone well even though the indicators in Regulation of the Minister of Health Number 74 of 2016 of the Republic of Indonesia had been realized. The process of planning and procuring drugs at the Kragan II Health Center (Puskesmas) experienced problems in the field of funding for the procurement of drugs due to the Covid-19 pandemic. Another problem is the PBF whose response is slow and the drugs distributed are not following what was ordered by the pharmacist.

Conclusion: Regarding debts with PBF, pharmacists are advised to discuss with the Head of the Kragan II Health Center regarding budget priorities during the COVID-19 pandemic to immediately pay off debts with PBF so that pharmacists can procure with PBF again. Therefore, drug services to patients can run well.

Note: This article has supplementary file(s).

Fulltext View|Download |  common.other
Untitled
Subject
Type Other
  Download (418KB)    Indexing metadata
Keywords: COVID-19 pandemic, Drug Planning, Drug Procurement

Article Metrics:

  1. Binagwaho A, Ghebreyesus TA. Primary healthcare is cornerstone of universal health coverage. In: The BMJ. 2019. p. 2391
  2. Rahmah F. Perencanaan dan Pengadaan Obat di Puskesmas “X” Berdasarkan Permenkes Nomor 74 Tahun 2016. J Adm Kesehat Indones. 2018;6(1):15
  3. Nibong CR, Kolibu FK, Mandagi CKF. Analisis Perencanaan dan Pengadaan Obat di Puskesmas Sario Kota Manado. J Kesehat Masy SAM RATULANGI [Internet]. 2017;6(3):1–12. Available from: https://ejournal.unsrat.ac.id/index.php/kesmas/article/view/23033
  4. Kementerian Kesehatan RI. Peraturan Menteri Kesehatan Republik Indonesia Nomor 74 Tahun 2016 Tentang Standar Pelayanan Kefarmasian di Puskesmas. Jakarta: Kemenkes RI; 2016. 1–48 p
  5. Alatas H, Karyomanggolo W, Musa DA, Boediarso A, Oesman IN, Idris NS. Desain Penelitian. In: Sastroasmoro S, Ismael S, editors. Dasar-dasar Metodologi Penelitian Klinis. 5th ed. Jakarta: Sagung Seto; 2014. p. 104–30
  6. Sugiyono. Metode Penelitian Kuantitatif, Kualitatif, dan R&D. 22nd ed. Bandung: ALFABETA CV; 2015. 205–277 p
  7. Roza S, Pratiwi E, Dewi RS, Sinata N. Gambaran Perencanaan dan Pengadaan Obat di Puskesmas Rawat Jalan Kabupaten Rokan Hulu Tahun 2018. J Penelit Farm Indones. 2019;8(2):85–90
  8. Puspadina V, Oetari O, Widodo GP. Evaluasi Performa Supply Chain Management Pedagang Besar Farmasi Terhadap Proses Pengadaan Di Apotek Kimia Farma Unit Bisnis Sidoarjo. JPSCR J Pharm Sci Clin Res. 2021;6(1):49

Last update:

No citation recorded.

Last update:

No citation recorded.